Print

Print


There are several issues here I think (and only my thoughts):

1.) the provided information is unclear as to the sequence generation so we cannot really say

2.) if at any stage, the central tenet of randomization which is unpredictability of future allocation, is breached, then the sequence generation is inadequate

3.) the goal of randomization is to ensure balance of known and unknown prognostic factors so that the effect can be allotted to 'only' the treatment under consideration...the way it is described below, we cannot say prognostic factors are balanced (at least thats how I read it)

4.) it is critical to understand what the allocation concealment strategy was for if it were deficient, or there were none, then no matter how good the sequence generation strategy (randomization) was, the randomization has failed...they go hand in hand

5.) the way it is described thus far, it appears (unless one can read the methods) that this was a form of minimization (adaptive randomization), so a deterministic form of randomization where the first entrant is randomized adequately where there is an equal probability of being assigned to either group and there is no predictability, but the other subsequent entrants to the trial are assigned based on prior assignment to achieve some form of prognostic balance. The researcher is guiding entrants to certain groups. The draw back with this form of randomization as you know (from what I understand) is that there is a form of determinism and thus one is violating the central tenet of randomization this being unpredictability (increased selection bias risk). Once you guide or determine the next assignment (e.g it appears they did to the AB group) and breach the 'no predictability', then one cannot say this is suitably randomized. To say assigned
 'sequentially' is not giving us enough information, and could mean one goes to group 1 the other to group 2 then the third to group 1 and the fourth to group 2 and so on..this is fraught with predictability. Thats how I read it. 

this is a very interesting question and the responses are very informative..thanks for sharing. 
 
 
 
 
 
Best,
Paul E. Alexander
 



--------------------------------------------
On Tue, 7/2/13, Dr. Ahmed M. Abou-Setta <[log in to unmask]> wrote:

 Subject: Re: randomisation
 To: [log in to unmask]
 Received: Tuesday, July 2, 2013, 2:52 AM
 
 
 
 
 I will have to disagree here... I'm
 not saying that this is a correct form of randomization, but
 rather it is an unclear form of randomization until we know
 more.
 
 The authors stated "We assigned participants to two
 groups by randomized sequential allocation. The first
 patient was randomly assigned to the LC group by tossing a
 coin, the second patient to the AB group, and the other
 patients were assigned to the two groups,
 sequentially." From this we can tell the following:
 
 A) 1st patient was properly randomized.
 B) 2nd patient was not quasi-randomized - unless they
 entered two patients in the study at the same time.
 C) Every patient after that may or may not have been
 properly randomized depending on whether or not they kept
 flipping coins or whether they used alternate
 randomization.
 
 This is the gray area where published protocols and
 contacting authors for additional information/ clarification
 comes in handy. In this case the protocol
 (http://www.irct.ir/searchresult.php?id=1658&number=1)
 doesn't help much. So the only remaining options are to
 either make a decision based on what is available in the
 published trial report or contact the author.
 
 Ahmed
 
 
 Date: Mon, 1 Jul 2013
 20:57:35 -0400
 From: [log in to unmask]
 Subject: Re: randomisation
 To: [log in to unmask]
 
 Hi Mark, 
 I agree with Valerie, it also appears this study
 was not blinded. We did a post  http://www.ithinkwell.org/why-is-randomization-needed-in-clinical-trials/
 and there is an excellent paper on this embedded written by
 Jeremy Howick and a great 5 minute video supplied by Dr
 Terry Shanyfelt. In the comments Paul Lucas has made some
 astute observations and even uses an autologous example, I
 hope this could be helpful , The guidelines I like best for
 RCTs and systematic reviews come from a program called CASP
 they are 10-11 point checklists with full explanations and
 are a great way to see what you have in a simple and fair
 way, they are free to download here under checklists http://www.casp-uk.net/
  `I always try to give pers a pass but sometimes you
 just cant! 
 BestAmy
 From:  Valerie King <[log in to unmask]>
 Reply-To:  Valerie
 King <[log in to unmask]>
 Date:  Monday, July
 1, 2013 8:29 PM
 To:  <[log in to unmask]>
 Subject:  Re:
 randomisation
 
 In a word,
 no.Could someone predict
 which group the next subject would be allocated to? Yes.
 Could that someone
 therefore not enroll said subject, or consent for enrollment
 differently, or hold off on enrollment, or some other action
 in order to get the subject the care that the someone really
 wanted or the subject really wanted? Of course, that someone
 could do those things. Therefore it isn’t adequate
 randomisation. Valerie J. King, MD,
 MPHDirector of Evidence
 and PolicyCenter for
 Evidence-based PolicyOregon Health &
 Science UniversityMailcode
 SN-4N3455 SW US Veterans
 Hospital Rd.Portland, OR 
 97239Voice:
 503-494-8694Fax:
 [log in to unmask] From:
 Evidence based health (EBH) [mailto:[log in to unmask]]
 On Behalf Of Mark Ayson
 Sent: Monday, July 01, 2013 5:05 PM
 To: [log in to unmask]
 Subject: randomisation Dear
 group I was
 wondering if you could help me. I am working on a report
 about autologous blood injections and have an RCT that
 describes their randomisation technique as follows: "We
 assigned participants to two groups by randomized sequential
 allocation. The first patient was randomly assigned to the
 LC group by tossing a coin, the second patient to the AB
 group, and the other patients were assigned to the two
 groups, sequentially."Is
 this techniques an adequate method of
 randomisation?I look
 forward to your comments. Kind
 regardsMark   
   
    
 
  
 Mark
 Ayson, MBChB,
 DPHResearch Advisor,
 Governance, Policy
 & Research, ACC
 
 Tel 04-8166386 / Fax 04-8167562 / Ext
 46386ACC / Research / Vogel House, 19 Aitken
 Street
 PO Box 242 / Wellington 6011 / New Zealand / www.acc.co.nz
 
 ACC cares about the environment – please don’t print
 this email
 unless it is really necessary. Thank you.
 
  
 
  
 
 
   
 
  Disclaimer:
 "This message and any attachments may contain
 confidential and privileged information. 
 If you believe you have received this email in error, please
 advise us immediately by 
 return email or telephone and then delete this email
 together with all attachments. 
 If you are not the intended recipient, you are not
 authorised to use or copy this message 
 or any attachments or disclose the contents to any other
 person. "